Oyster Point Pharma, Inc. Gains 38.56%

Mon, Nov 07, 2022 at 07:51 PM
Oyster Point Pharma, Inc. Gains 38.56%

Oyster Point Pharma, Inc. (OYST:NASDAQ) rocketted at $11.57, a gain of 38.6%. On Mon, Nov 07, 2022, OYST:NASDAQ hit a New 2-Week High of $11.57. The stock appeared on our News Catalysts scanner on Mon, Nov 07, 2022 at 09:31 AM in the 'ACQUISITION' category. From Tue, Oct 25, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days

About Oyster Point Pharma, Inc. (OYST:NASDAQ)

Oyster Point Pharma Inc is a biopharmaceutical company focused on the development of pharmaceutical therapies to treat ocular surface diseases. Its product candidate OC-01 is a nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.